InsiderDB

Rep. Kevin Hern sold Exact Sciences (EXAS)

Rep. Kevin Hern (R-OK-1) · $1K–$15K · traded Mar 24, 2026

Transaction
Sold
Amount
$1K–$15K
Owner
Dependent
Traded
Mar 24, 2026
Disclosed
Apr 3, 2026
Days to disclose
10
Asset type
Stock
As filed
Exact Sciences Corporation - Common Stock
Industry
Medical - Diagnostics & Research · Healthcare

Other trades in this filing

Recent Congress trades in EXAS

Company context for EXAS

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. EXASLobbying report·Lobbying disclosures

    EXAS: third_quarter 2026 lobbying report

    H.R.7118 Genomic Answers for Children's Health Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests

    Public: Oct 16, 2026, 11:03 PM EDTOriginal source ↗
  2. EXASLobbying report·Lobbying disclosures

    EXAS: second_quarter 2026 lobbying report

    H.R.7118 Genomic Answers for Children's Health Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests

    Public: Jul 18, 2026, 7:41 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.